Related Experiment Video
Updated: Jul 30, 2026

Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice
Published on: February 8, 2016
Chitosan-glucose derivative as effective wall material for probiotic yeasts microencapsulation.
Ladislao I Díaz Vergara1, Joaquín Arata Badano1, Carla A Aminahuel1
1Instituto Multidisciplinario de Investigación y Transferencia Agroalimentaria y Biotecnológica (IMITAB), Universidad Nacional de Villa María, Campus Universitario, Av. Arturo Jauretche 1555, Villa María, Córdoba, Argentina.
A novel chitosan-glucose derivative (ChG) offers enhanced antioxidant properties and improved probiotic yeast microencapsulation. This ChG material shows promise for protecting beneficial microbes during storage and simulated digestion.
Area of Science:
- Biomaterials Science
- Food Science and Technology
- Microbiology
Background:
- Chitosan is a widely used biopolymer, but its native form may exhibit limitations for specific applications.
- Probiotic yeast encapsulation requires protective materials that maintain viability and functionality.
- The Maillard reaction offers a method to modify biopolymers like chitosan.
Purpose of the Study:
- To synthesize and characterize a chitosan-glucose derivative (ChG) via the Maillard reaction.
- To evaluate the antioxidant, cytotoxic, and antimicrobial properties of the synthesized ChG.
- To assess the efficacy of ChG as a wall material for spray-dried microencapsulation of the probiotic yeast *K. marxianus* VM004.
Main Methods:
- Synthesis of ChG using the Maillard reaction.
- Characterization of ChG using FT-IR, 1H NMR, and SLS to determine structure, deacetylation degree (DD), and molecular weight (Mw).
- Evaluation of antioxidant, cytotoxic, and antimicrobial activities of ChG.
- Microencapsulation of *K. marxianus* VM004 using ChG as a wall material via spray drying.
- Characterization of microcapsules for encapsulation efficiency, morphology, gastrointestinal tolerance, and storage stability.
Main Results:
- The Maillard reaction yielded a ChG derivative with lower molecular weight and deacetylation degree but enhanced antioxidant activity compared to native chitosan.
- The synthesized ChG was non-cytotoxic.
- ChG microcapsules containing *K. marxianus* VM004 demonstrated high encapsulation efficiency (>57%).
- Microcapsules exhibited improved tolerance to simulated gastrointestinal conditions and enhanced storage stability.
Conclusions:
- The chitosan-glucose derivative (ChG) synthesized via the Maillard reaction possesses favorable antioxidant and non-cytotoxic properties.
- ChG is an effective wall material for microencapsulating probiotic yeast *K. marxianus* VM004.
- ChG microcapsules provide enhanced protection to probiotic yeast, improving their stability and survival under challenging conditions, indicating potential for functional food applications.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Microbes in Food Production

